Page 319 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Systemic Vasculitis of the Gastrointestinal Tract 293

[39] Stenwig JT. Intestinal gangrene due to giant-cell arteritis. J. Oslo City Hosp. 1976;
26:49-55.

[40] Smith JAE, O’Sullivan M, Gough J, et al. Small intestinal perforation secondary to
localised giant-cell arteritis of the mesenteric vessels. Br. J. Rheumatol. 1988; 27:236-
238.

[41] Srigley JR, Gardiner GW. Giant cell arteritis with small bowel infarction. Am. J.
Gastroenterol. 1980; 78:157-161.

[42] Krant JD, Ross JM. Extracranial giant cell arteritis restricted to the small bowel.
Arthritis. Rheum. 1992; 35:603-604.

[43] Evans DJ, Wilkins MJ, Wazir JF, et al. Extracranial giant cell arteritis. J. R. Coll. Surg.
Edinb. 1998; 43:207-208.

[44] Tsuyuoka R, Takahashi T, Shinoda E, et al. Intestinal perforation in temporal arteritis,
associated with paroxysmal nocturnal hemoglobinuria. Intern. Med. 1996; 35:159-161.

[45] Phelan MJI, Kok K, Burrow C, et al. Small bowel infarction in association with giant
cell arteritis. Br. J. Rheumatol. 1993; 32:63-65.

[46] Ljungstrom K, Strandberg O, Sandstedt B. Infarction of the small bowel caused by
giant cell arteritis. Acta. Chir. Scand. 1989; 155:361-363.

[47] Cantini F, Niccoli L, Salvarani C, et al. Treatment of longstanding active giant cell
arteritis with infliximab: report of four cases. Arthritis. Rheum. 2001; 44:2933-2935.

[48] Seitz M, Reichenbach S, Bonel HM, et al. Rapid induction of remission in large vessel
vasculitis by IL-6 blockade. A case series. Swiss Med. Wkly 2011; 141:w13156.

[49] Pagnoux C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients
with polyarteritis nodosa: A systematic retrospective study of patients diagnosed
between 1963 and 2005 and entered into the French vasculitis study group database.
Arthritis. Rheum. 2010; 62:616-626.

[50] Guillevin L, Mahr A, Callard P, et al. Hepatitis B virus-associated polyarteritis nodosa:
clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine
2005; 84:313-22.

[51] Ebert EC, Haqspiel KD, Nagar M, et al. Gastrointestinal involvement in polyarteritis
nodosa. Clin. Gastroenterol. Hepatol 2008; 6:960-966.

[52] Pagnouz C, Seror R, Henegar C, et al. Clinical features and outcomes in 348 patients
with polyarteritis nodosa: A systematic retrospective study of patients diagnosed
between 1963 and 2005 and entered into the French vasculitis study group database.
Arthritis. Rheum. 2010; 62:616-626.

[53] Pagnoux C, Mahr A, Cohen P, et al. Presentation and outcome of gastrointestinal
involvement in systemic necrotizing vasculitides: analysis of 62 patients with
polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss
syndrome, or rheumatoid arthritis associated vasculitis Medicine 2005; 84:115-1128.

[54] Travers RL, Allison DJ, Brettle RP, et al. Polyarteritis nodosa: a clinical and
angiographic analysis of 17 cases. Semin. Arthritis. Rheum. 1979; 8:184-189.

[55] Mowrey FH, Lundberg EA. The clinical manifestations of essential polyarteritis nodosa
(periarteritis nodosa) with emphasis on the hepatic manifestations. Ann. Intern. Med.
1954; 40:1145-1164.

[56] Levine SM, Hellmann DB, Stone JH. Gastrointestinal involvement in polyarteritis
nodosa (1986-2000): presentation and outcomes in 24 patients. Am. J. Med. 2002;
112:386-391.

Complimentary Contributor Copy